China Universal Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 23,910 shares of ARWR stock, worth $511,913. This represents 0.05% of its overall portfolio holdings.
Number of Shares
23,910
Previous 14,592
63.86%
Holding current value
$511,913
Previous $379,000
21.9%
% of portfolio
0.05%
Previous 0.05%
Shares
14 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
91.1MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$336 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$262 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$190 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$136 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$105 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.27B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...